Comparative Pharmacology
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus DROSPIRENONE AND ESTRADIOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus DROSPIRENONE AND ESTRADIOL.
DIETHYLSTILBESTROL vs DROSPIRENONE AND ESTRADIOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen that binds to estrogen receptors (ERα/ERβ), activating estrogen-responsive gene transcription, leading to proliferation of estrogen-sensitive tissues.
Drospirenone is a progestin with antimineralocorticoid and antiandrogenic activity; estradiol is an estrogen. Drospirenone acts as a progesterone receptor agonist, inhibits ovulation, and increases cervical mucus viscosity. Estradiol replaces endogenous estrogen, suppresses gonadotropin secretion.
0.5-2 mg orally once daily for palliative treatment of advanced prostate cancer; 5-15 mg orally once daily for prevention of postpartum breast engorgement.
One tablet (drospirenone 3 mg / estradiol 0.5 mg) orally once daily for hormone therapy.
None Documented
None Documented
Clinical Note
moderateDiethylstilbestrol + Digoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateDiethylstilbestrol + Digitoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateDiethylstilbestrol + Deslanoside
"Diethylstilbestrol may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateDiethylstilbestrol + Acetyldigitoxin
Terminal elimination half-life is approximately 24 hours (range 20-30 hours) in adults; prolonged in hepatic impairment.
Drospirenone: ~30-40 hours (allows once-daily dosing); estradiol: ~12-15 hours (after oral administration).
Primarily renal (90% as glucuronide and sulfate conjugates), with less than 5% excreted unchanged in urine; biliary/fecal elimination accounts for about 10%.
Drospirenone: ~40-50% renal, ~50-60% fecal; estradiol: ~60-80% renal (as metabolites), ~20-40% fecal.
Category C
Category D/X
Estrogen
Estrogen
"Diethylstilbestrol may decrease the cardiotoxic activities of Acetyldigitoxin."